002 Switching treatments of etanercept biosimilar GP2015...

002 Switching treatments of etanercept biosimilar GP2015 with originator product does not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis

Griffiths, C.E., Reich, K., Thaçi, D., Gerdes, S., Arenberger, P., Kingo, K., Weglowska, J., Woehling, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.098
Date:
October, 2017
File:
PDF, 240 KB
english, 2017
Conversion to is in progress
Conversion to is failed